Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human ATG3 ELISA Kit (AC3648)
Cat.#: ASET-2237
Specifications
Description Human ATG3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human ATG3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.015 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.5-8 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1747 Porcine Angiogenin ELISA Kit (AC3158) Quantitative inquiry ASET-2192 Human CRHR2 ELISA Kit (AC3603) Quantitative inquiry ASET-1595 Human SPTBN2 ELISA Kit (AC3006) Quantitative inquiry ASET-1292 Human Glucose 6 Phosphate Isomerase ELISA Kit (AC2703) Quantitative inquiry ASET-1134 Human NRXN3 ELISA Kit (AC2545) Quantitative inquiry ASET-1590 Human SEMA4A ELISA Kit (AC3001) Quantitative inquiry ASET-1268 Human Plexin A1 ELISA Kit (AC2679) Quantitative inquiry ASET-2196 Human VMAT2 ELISA Kit (AC3607) Quantitative inquiry ASET-1240 Human Reelin ELISA Kit (AC2651) Quantitative inquiry ASET-1832 Human NCAM1 ELISA Kit (AC3243) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket